Announcement

Collapse
No announcement yet.

Trends Immunol. Neutralizing Antibodies against SARS-CoV-2 and Other Human Coronaviruses

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts

  • Trends Immunol. Neutralizing Antibodies against SARS-CoV-2 and Other Human Coronaviruses


    Trends Immunol. 2020 Apr 2. pii: S1471-4906(20)30057-0. doi: 10.1016/j.it.2020.03.007. [Epub ahead of print]
    Neutralizing Antibodies against SARS-CoV-2 and Other Human Coronaviruses.


    Jiang S1, Hillyer C2, Du L3.

    Author information




    Abstract

    Coronavirus (CoV) disease 2019 (COVID-19) caused by severe acute respiratory syndrome (SARS)-CoV-2 (also known as 2019-nCoV) is threatening global public health, social stability, and economic development. To meet this challenge, this article discusses advances in the research and development of neutralizing antibodies (nAbs) for the prevention and treatment of infection by SARS-CoV-2 and other human CoVs.
    Copyright ? 2020 The Author(s). Published by Elsevier Ltd.. All rights reserved.



    KEYWORDS:

    MERS-CoV; SARS-CoV; SARS-CoV-2; human coronaviruses; neutralizing antibodies


    PMID:32249063DOI:10.1016/j.it.2020.03.007
    Free full text

Working...
X